Agitation in Alzheimer’s disease: From assessment to therapeutics

Figure 2 Flowchart outlining the management of agitation in Alzheimer’s disease. Acute agitation requires ruling out delirium and addressing modifiable risk factors, followed by the consideration of atypical antipsychotics and/or benzodiazepines alongside non-pharmacological interventions. Chronic agitation also involves addressing modifiable factors, with treatment options including selective serotonin recapture inhibitors, atypical antipsychotics, and non-pharmacological approaches. PFC: Prefrontal cortex.